A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Aug 18, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the FN SEC filings page.
Fabrinet (FN) reported $4.6B in revenue for fiscal year 2026, up 35.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Rapid expansion is increasingly absorbing cash as capital investment and working-capital needs outpace reported profit.
Despite net margin reaching10.2% in FY2026, free-cash-flow margin collapsed to0.1% , revealing a cash-conversion gap: accounting profitability is not currently translating into cash after reinvestment.
FY2026 revenue reached
Debt-to-equity climbed from 0.4x to 0.6x in FY2026, showing expansion was accompanied by a more leveraged balance sheet rather than funded solely by retained earnings. The current ratio eased to 2.3x as inventory and receivables expanded, linking weaker cash conversion to more funds tied up in operations. Capital spending rose from
Financial Health Signals
Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Fabrinet's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Fabrinet has an operating margin of 10.0%, meaning the company retains $10 of operating profit per $100 of revenue. This strong profitability earns a score of 76/100, reflecting efficient cost management and pricing power. This is up from 9.5% the prior year.
Fabrinet's revenue surged 35.7% year-over-year to $4.6B, reflecting rapid business expansion. This strong growth earns a score of 88/100.
Fabrinet has a moderate D/E ratio of 0.59. This balance of debt and equity financing earns a leverage score of 57/100.
With a current ratio of 2.25, Fabrinet holds $2.25 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.
While Fabrinet generated $256.7M in operating cash flow, capex of $252.5M consumed most of it, leaving $4.2M in free cash flow. This results in a low score of 43/100, reflecting heavy capital investment rather than weak cash generation.
Fabrinet earns a strong 19.3% return on equity (ROE), meaning it generates $19 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 88/100. This is up from 16.8% the prior year.
Fabrinet scores 8.87, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($14.2B) relative to total liabilities ($1.5B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Fabrinet passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Fabrinet generates $0.54 in operating cash flow ($256.7M OCF vs $473.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.
Fabrinet earns $5,510.56 in operating income for every $1 of interest expense ($462.9M vs $84K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Fabrinet generated $1.3B in revenue in Q4 2026. This represents an increase of 44.6% from the same quarter a year earlier. Against the prior quarter it is up 8.4%.
Fabrinet's EBITDA was $153.9M in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 49.0% from the same quarter a year earlier. Against the prior quarter it is up 11.6%.
Fabrinet reported $139.3M in net income in Q4 2026. This represents an increase of 59.7% from the same quarter a year earlier. Against the prior quarter it is up 11.2%.
Fabrinet earned $3.83 per diluted share (EPS) in Q4 2026. This represents an increase of 58.3% from the same quarter a year earlier. Against the prior quarter it is up 11.0%.
Cash & Balance Sheet
Fabrinet recorded an outflow of $36.9M in free cash flow in Q4 2026, representing a cash shortfall after capex. This represents a decrease of 888.0% from the same quarter a year earlier. Against the prior quarter it is down 240.8%.
Fabrinet held $346.7M in cash as of Q4 2026; long-term debt is not reported for that period.
Not reported for Q4 2026.
Margins & Returns
Fabrinet's gross margin was 12.0% in Q4 2026, indicating the percentage of revenue retained after direct costs. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.
Fabrinet's operating margin was 10.2% in Q4 2026, reflecting core business profitability. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Fabrinet's net profit margin was 10.6% in Q4 2026, showing the share of revenue converted to profit. This is up 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.3 percentage points.
Fabrinet's ROE was 5.7% in Q4 2026, measuring profit generated per dollar of shareholder equity. This is up 1.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.2 percentage points.
Capital Allocation
Fabrinet repurchased no shares in Q4 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Fabrinet invested $91.9M in capex in Q4 2026, funding long-term assets and infrastructure. This represents an increase of 82.2% from the same quarter a year earlier. Against the prior quarter it is up 44.1%.
Not reported for Q4 2026.
FN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B+44.6% | $1.2B+39.3% | $1.1B+35.9% | $978.1M+21.6% | $909.7M+20.8% | $871.8M+19.2% | $833.6M+17.0% | $804.2M+17.3% |
| Cost of Revenue | $1.2B+45.0% | $1.1B+39.0% | $995.2M+35.8% | $861.7M+22.2% | $798.4M+20.8% | $769.6M+20.1% | $732.8M+17.4% | $705.2M+17.3% |
| Gross Profit | $158.1M+42.0% | $144.3M+41.3% | $137.7M+36.5% | $116.4M+17.6% | $111.3M+20.4% | $102.2M+12.4% | $100.8M+14.2% | $99.0M+17.3% |
| SG&A Expenses | $23.7M+6.9% | $24.3M+10.1% | $23.3M+9.8% | $22.2M+1.0% | $22.2M+16.0% | $22.1M+12.4% | $21.2M+9.8% | $22.0M+7.8% |
| Operating Income | $134.2M+50.7% | $120.0M+52.2% | $114.4M+43.7% | $94.2M+22.4% | $89.1M+21.5% | $78.9M+10.6% | $79.6M+15.3% | $76.9M+20.3% |
| EBITDA | $153.9M+49.0% | $137.8M+49.4% | $130.5M+40.9% | $109.1M+21.6% | $103.3M+20.5% | $92.3M+10.2% | $92.6M+14.0% | $89.7M+18.1% |
| Interest Expense | N/A | N/A | N/A | N/A | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% |
| Income Tax | $60.5M+902.8% | $9.0M+80.4% | $7.1M-14.0% | $5.5M+63.6% | $6.0M+54.2% | $5.0M+108.8% | $8.3M+117.6% | $3.4M-33.7% |
| Net Income | $139.3M+59.7% | $125.2M+54.0% | $112.6M+30.0% | $95.9M+23.9% | $87.2M+7.6% | $81.3M+0.5% | $86.6M+25.4% | $77.4M+18.9% |
| EPS (Basic) | $3.89+60.1% | $3.49+54.4% | $3.14+30.8% | $2.68+25.2% | $2.43+8.5% | $2.26+1.3% | $2.40+26.3% | $2.14+18.9% |
| EPS (Diluted) | $3.83+58.3% | $3.45+53.3% | $3.11+30.7% | $2.66+24.9% | $2.42+9.0% | $2.25+1.8% | $2.38+25.9% | $2.13+19.7% |
| Diluted Shares (Avg) | N/A | 36M+0.4% | 36M-0.4% | 36M-0.9% | N/A | 36M-1.2% | 36M-0.6% | 36M-0.2% |
Not reported in any period shown, so not listed: R&D Expenses.
FN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.9B+38.1% | $3.5B+34.0% | $3.3B+28.6% | $3.0B+23.4% | $2.8B+21.1% | $2.6B+17.1% | $2.5B+19.2% | $2.4B+20.8% |
| Current Assets | $3.2B+30.1% | $2.9B+31.2% | $2.8B+26.1% | $2.6B+21.3% | $2.4B+20.7% | $2.2B+17.1% | $2.2B+21.7% | $2.1B+24.6% |
| Cash & Equivalents | $346.7M+13.1% | $356.6M+16.2% | $319.9M-20.8% | $305.0M-23.9% | $306.4M-25.3% | $306.9M-20.3% | $403.7M+20.8% | $400.7M+29.9% |
| Short-Term Investments | $528.3M-15.8% | $588.7M-8.6% | $640.9M+20.7% | $663.8M+30.6% | $627.8M+39.9% | $643.8M+57.4% | $531.0M+30.6% | $508.2M+40.2% |
| Inventory | $1.0B+75.8% | $876.0M+64.9% | $798.9M+63.3% | $722.2M+64.0% | $581.0M+25.4% | $531.3M+17.0% | $489.2M+17.9% | $440.4M+0.1% |
| Accounts Receivable | $1.0B+34.1% | $908.5M+38.0% | $801.7M+17.9% | $706.9M+6.7% | $758.9M+28.1% | $658.3M+12.7% | $680.1M+16.3% | $662.7M+23.9% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.5B+71.5% | $1.2B+69.1% | $1.1B+55.0% | $947.6M+54.7% | $849.6M+43.3% | $712.1M+23.5% | $699.4M+34.1% | $612.4M+25.2% |
| Current Liabilities | $1.4B+73.2% | $1.2B+71.2% | $1.0B+56.3% | $905.5M+57.2% | $809.8M+45.1% | $675.0M+24.0% | $663.2M+36.2% | $576.0M+26.5% |
| Non-Current Liabilities | $54.1M+36.0% | $48.7M+31.5% | $47.2M+30.1% | $42.1M+15.4% | $39.8M+14.2% | $37.1M+14.0% | $36.3M+3.7% | $36.4M+8.4% |
| Total Equity | $2.5B+23.8% | $2.3B+20.8% | $2.2B+18.5% | $2.1B+12.8% | $2.0B+13.5% | $1.9B+14.9% | $1.8B+14.4% | $1.8B+19.4% |
| Retained Earnings | $2.6B+22.6% | $2.4B+21.0% | $2.3B+19.6% | $2.2B+19.1% | $2.1B+18.9% | $2.0B+19.4% | $1.9B+20.4% | $1.8B+20.2% |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
FN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $55.0M-0.2% | $52.9M-28.7% | $46.3M-60.1% | $102.6M+23.3% | $55.1M-33.7% | $74.2M-26.5% | $115.9M+37.7% | $83.2M-42.7% |
| Depreciation & Amortization | $19.6M+38.0% | $17.8M+32.5% | $16.1M+23.5% | $14.9M+16.5% | $14.2M+14.5% | $13.4M+8.1% | $13.0M+6.7% | $12.8M+6.6% |
| Stock-Based Compensation | N/A | $8.5M+9.7% | $8.8M+3.8% | $9.1M+4.5% | N/A | $7.8M+15.7% | $8.4M+20.9% | $8.7M+12.3% |
| Capital Expenditures | $91.9M+82.2% | $63.8M+123.6% | $51.6M+135.7% | $45.3M+123.5% | $50.4M+296.8% | $28.5M+109.9% | $21.9M+123.4% | $20.3M+77.1% |
| Free Cash Flow | -$36.9M-888.0% | -$10.8M-123.7% | -$5.3M-105.7% | $57.3M-8.9% | $4.7M-93.3% | $45.7M-47.7% | $94.0M+26.4% | $62.9M-52.9% |
| Investing Cash Flow | -$63.8M-92.2% | -$13.7M+90.0% | -$25.2M+42.9% | -$81.0M-12.5% | -$33.2M+35.1% | -$137.1M-717.6% | -$44.1M+9.6% | -$72.0M-35.6% |
| Financing Cash Flow | -$1.1M+95.3% | -$917K+97.4% | -$5.7M+91.7% | -$23.0M-13.6% | -$22.6M-220.6% | -$35.0M-6.1% | -$69.2M-619.0% | -$20.2M-33.1% |
| Share Buybacks | $0-100.0% | $151K-99.6% | $4.8M-93.0% | $268K | $22.3M+527.5% | $34.8M+17.6% | $68.7M+978.2% | $0 |
Not reported in any period shown, so not listed: Dividends Paid.
FN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 12.0%-0.2pp | 11.9%+0.2pp | 12.2%+0.1pp | 11.9%-0.4pp | 12.2%0.0pp | 11.7%-0.7pp | 12.1%-0.3pp | 12.3%0.0pp |
| Operating Margin | 10.2%+0.4pp | 9.9%+0.8pp | 10.1%+0.6pp | 9.6%+0.1pp | 9.8%+0.1pp | 9.0%-0.7pp | 9.6%-0.1pp | 9.6%+0.2pp |
| Net Margin | 10.6%+1.0pp | 10.3%+1.0pp | 9.9%-0.5pp | 9.8%+0.2pp | 9.6%-1.2pp | 9.3%-1.7pp | 10.4%+0.7pp | 9.6%+0.1pp |
| Return on Equity | 5.7%+1.3pp | 5.4%+1.2pp | 5.2%+0.5pp | 4.7%+0.4pp | 4.4%-0.2pp | 4.3%-0.6pp | 4.7%+0.4pp | 4.2%0.0pp |
| Return on Assets | 3.6%+0.5pp | 3.6%+0.5pp | 3.5%0.0pp | 3.2%0.0pp | 3.1%-0.4pp | 3.1%-0.5pp | 3.4%+0.2pp | 3.2%-0.1pp |
| Current Ratio | 2.25-0.7x | 2.55-0.8x | 2.68-0.6x | 2.83-0.8x | 3.00-0.6x | 3.32-0.2x | 3.32-0.4x | 3.66-0.1x |
| Debt-to-Equity | 0.59+0.2x | 0.52+0.1x | 0.50+0.1x | 0.46+0.1x | 0.43+0.1x | 0.370.0x | 0.38+0.1x | 0.340.0x |
| Asset Turnover | 0.340.0x | 0.350.0x | 0.350.0x | 0.330.0x | 0.320.0x | 0.330.0x | 0.330.0x | 0.330.0x |
| FCF Margin | -2.8%-3.3pp | -0.9%-6.1pp | -0.5%-11.8pp | 5.9%-2.0pp | 0.5%-8.8pp | 5.2%-6.7pp | 11.3%+0.8pp | 7.8%-11.7pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Fabrinet FN | FY2026 | $4.6B | $473.0M | 10.2% | $14.2B | 70/100 |
| Flex Ltd FLEX | FY2026 | $27.9B | $880.0M | 3.1% | $39.1B | 51/100 |
| Jabil Inc JBL | FY2025 | $29.8B | $657.0M | 2.2% | $31.4B | 49/100 |
| Celestica CLS | FY2025 | $12.4B | $832.5M | 6.7% | $35.0B | 65/100 |
| Te Conne TEL | FY2025 | $17.3B | $1.8B | 10.7% | $58.5B | 66/100 |
| Corning GLW | FY2025 | $15.6B | $1.6B | 10.2% | $126.8B | 47/100 |
Where Fabrinet Ranks
Frequently Asked Questions
What is Fabrinet's annual revenue?
Fabrinet (FN) reported $4.6B in total revenue for fiscal year 2026. This represents a 35.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Fabrinet's revenue growing?
Fabrinet (FN) revenue grew by 35.7% year-over-year, from $3.4B to $4.6B in fiscal year 2026.
Is Fabrinet profitable?
Yes, Fabrinet (FN) reported a net income of $473.0M in fiscal year 2026, with a net profit margin of 10.2%.
What is Fabrinet's EBITDA?
Fabrinet (FN) had EBITDA of $531.3M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.
What is Fabrinet's gross margin?
Fabrinet (FN) had a gross margin of 12.0% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.
What is Fabrinet's operating margin?
Fabrinet (FN) had an operating margin of 10.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
What is Fabrinet's net profit margin?
Fabrinet (FN) had a net profit margin of 10.2% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.
What is Fabrinet's return on equity (ROE)?
Fabrinet (FN) has a return on equity of 19.3% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
What is Fabrinet's free cash flow?
Fabrinet (FN) generated $4.2M in free cash flow during fiscal year 2026. This represents a -98.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Fabrinet's operating cash flow?
Fabrinet (FN) generated $256.7M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
What are Fabrinet's total assets?
Fabrinet (FN) had $3.9B in total assets as of fiscal year 2026, including both current and long-term assets.
What are Fabrinet's capital expenditures?
Fabrinet (FN) invested $252.5M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.
What is Fabrinet's current ratio?
Fabrinet (FN) had a current ratio of 2.25 as of fiscal year 2026, which is generally considered healthy.
What is Fabrinet's debt-to-equity ratio?
Fabrinet (FN) had a debt-to-equity ratio of 0.59 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Fabrinet's return on assets (ROA)?
Fabrinet (FN) had a return on assets of 12.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
What is Fabrinet's P/E ratio?
Fabrinet (FN) trades at 29.9x earnings, its market capitalization divided by net income of $473.0M net income, FY2026. The market capitalization is $14.2B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Fabrinet's price-to-sales ratio?
Fabrinet (FN) trades at 3.0x sales, its market capitalization divided by revenue of $4.6B revenue, FY2026. The market capitalization is $14.2B as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Fabrinet's Altman Z-Score?
Fabrinet (FN) has an Altman Z-Score of 8.87, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Fabrinet's Piotroski F-Score?
Fabrinet (FN) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Fabrinet's earnings high quality?
Fabrinet (FN) has an earnings quality ratio of 0.54x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Fabrinet cover its interest payments?
Fabrinet (FN) has an interest coverage ratio of 5,510.56x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Fabrinet?
Fabrinet (FN) scores 70 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.